CEP Magazine
Should Highly Regulated Public Companies Have Board-Level Compliance Committees?
November 2021
In this CEP Magazine article, Sidley partners Holly J. Gregory and Paul E. Kalb, MD, the co-chair of Sidley’s Executive Compensation and Corporate Governance practice and the global head of Sidley’s Healthcare and FDA Group, respectively, discuss the considerations evaluating whether highly regulated public companies should have board-level compliance committees.
Copyright 2021 CEP Magazine, a publication of the Society of Corporate Compliance and Ethics (SCCE).
Offices
Capabilities
Suggested News & Insights
California Appellate Court Affirms Enforceability of Federal Forum Provisions in Securities Act LitigationDecember 17, 2025Sidley Represents ABM In Its US$275 Million Acquisition of WGNSTARDecember 17, 2025Sidley Elects Partnership Class of 29 and Counsel Class of 15 Across Europe and U.S.December 11, 2025Court of Chancery Reaffirms High Bar for Challenging Advance Notice Bylaws, but Emphasizes the Importance of Clear DraftingDecember 10, 2025When a Whistleblower Complaint Becomes a Board-Level “Red Flag”December 3, 2025Board Oversight of AI Risk Through an Ethical LensNovember 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory